Navigation Links
Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008

- Data demonstrates safety and efficacy of first FDA-approved nebulized

formoterol fumarate in patients with moderate to severe COPD -

NAPA, Calif., May 16 /PRNewswire/ -- Dey, L.P. announced today that three clinical data presentations will be given at the International Conference of the American Thoracic Society (ATS) on May 20, 2008 at the Metro Toronto Convention Center. One of the presentations details the effects on dyspnea and other COPD symptoms of using Perforomist(TM) Inhalation Solution, nebulized formoterol fumarate, adjunctively with tiotropium to treat COPD patients. The other two presentations compare the clinical effect of two types of drug delivery - nebulization versus DPI - when treating COPD patients with formoterol fumarate.

Perforomist(TM) (formoterol fumarate) Inhalation Solution was approved in 2007 by the FDA for long-term, twice-daily maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is the only FDA- approved nebulized formoterol fumarate.

For those attending ATS, the three presentations are available as follows:

-- "Addition of Nebulized Formoterol Fumarate to Tiotropium Treatment

Relieves Dyspnea and Symptoms in COPD Patients," Poster Board #F4

-- "Dose-Ranging Study in COPD Patients Comparing Pharmacodynamics of

Formoterol Fumarate Delivered by Nebulization and DPI," Poster Board


-- "A Pharmacokinetic Study in COPD Patients Comparing Formoterol Fumarate

Delivered by Nebulization and DPI," Poster Board #F14

Poster Viewing: Tuesday May 20th, 10:45 AM - 12:15 PM EDT

Room: Area F (Halls A-B, North Building, Level 300), Metro Toronto

Convention Centre

Session Info: Thematic Poster Session, [C42] COPD Pharmacotherapy I:

Effects of Bronchodilators

Please note that the principal investigators will be

Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Radiologists encouraged to look beyond cancer for clinically unseen diseases
2. Clinical depression linked to abnormal emotional brain circuits
3. Preclinical study suggests organ-transplant drug may aid in lupus fight
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Good Clinical Practice Journal Awards: Winners Announced
6. Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit
7. Study Questions Dead-End Cancer Clinical Trials
8. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
9. Clinical trials present better alternatives for dialysis patients
10. Mirixa Debuts New Clinical Technology Solutions for Enhancing Patient Care
11. IMPACT initiative looks to improve patient participation in clinical trials
Post Your Comments:
(Date:10/9/2015)... ... October 09, 2015 , ... ViewPoint Center, a teen mental ... teenagers facing mental illness, the stigma associated with mental illness causes many to hide ... understands the importance of supporting teens with mental illness , providing teens with ...
(Date:10/9/2015)... ... October 09, 2015 , ... ... placement counseling, recently opened its newest office in Maryland – its Bethesda ... with a background as a project management technology consultant to many of the ...
(Date:10/9/2015)... ... ... race options will be available for the Run 4 Recovery sponsored by WestBridge ... 4810 North Himes Avenue, in Tampa. The family friendly event will start with opening remarks ... a one-mile walk, followed by an award ceremony at 10 a.m. As part of a ...
(Date:10/9/2015)... ... October 09, 2015 , ... Safe Space, a non-profit organization ... launched a new website to mark Domestic Violence Awareness Month. , This ... immediately, whether through an emergency hotline, support group, or shelter. The revamped site ...
(Date:10/9/2015)... ... October 09, 2015 , ... Bag Tags Inc. will provide ... the media at the annual IRONMAN World Championship in Kailua-Kona, Hawaii, this ... which has taken place in Hawaii every year since 1978. , As part ...
Breaking Medicine News(10 mins):
... Dec. 18 Cyberonics, Inc. (Nasdaq:,CYBX) announced that ... an agreement with Ethicon Endo-Surgery granting exclusive rights ... vagus nerve,stimulation (VNS) for the treatment of obesity ... patients., Ethicon Endo-Surgery has agreed to pay ...
... HILL, N.C., Dec. 18 Despite all the ... a long and,expensive trip from the lab to ... money pay off, best-in-class pharmaceutical companies have learned,to ... process,according to research from Best Practices, LLC., ...
... team of scientists that includes a Saint Louis University ... of brain diseases that include multiple sclerosis, Alzheimers disease, ... Lancet Neurology. , Their review article, which focuses on ... available in an early online edition of the prestigious ...
... stick to the same guidelines about alcohol consumption as ... to the over 65s, and may even bring health ... School in the South West of England. , Researchers ... in England and the US and looked at the ...
... Hemodynamic and Implantability Characteristics, MINNEAPOLIS, Dec. ... ), manufacturer and marketer of state-of-the-art cardiac,surgery ... and Drug,Administration (FDA) approval for the ATS ... ), The ATS AP360 ...
... will be running the,story December 17th and 18th on ... TO A NEW ROBOT THAT MEASURES AND MIXES THEIR,TREATMENT., ... and,a patient were interviewed by CBS News. The story ... syringes and IV bags.,University of Colorado Hospital and Baylor ...
Cached Medicine News:
(Date:10/9/2015)... Calif. , Oct. 9, 2015  Impax Laboratories, ... Company will release its third quarter 2015 financial results ... of the U.S. financial markets. The Company will host ... community at 8:30 a.m., Eastern Time on November 9, ... . --> The financial results and ...
(Date:10/9/2015)... Oct. 9, 2015 AcelRx Pharmaceuticals, Inc. (NASDAQ: ... at the annual European Society of Emergency Medicine (EuSEM) meeting ... th , 2015 at the Lingotto Congress Centre in ... largest meeting of emergency medicine practitioners in the world with ... Data from the previously announced phase 2 bunionectomy trial ...
(Date:10/9/2015)... 9, 2015 Adheron Therapeutics, a privately ... California , United States ... be acquired by Roche.  Adheron Therapeutics has developed ... through a cell surface protein called Cadherin-11 in ... of inflammatory and autoimmune diseases such as rheumatoid ...
Breaking Medicine Technology:
... 2011   PLC Medical Systems, Inc. (OTC: PLCSF) today ... DATE: , October 6, 2011TIME: , 11:00 ... red "register/ watch event now" button.This will be a ... ask the company questions in real-time both in the ...
... Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) ... announces that it has acquired 63.9% of Société ... ("Promopharm" or the "Company") from a consortium of ... for an aggregate cash consideration of $111.2  million ...
Cached Medicine Technology:
... assay is a sensitive, simple ... permits the detection of all ... and can distinguish between ... P. vivax . In addition, ...
Malaria Pf/Pv Assay Range...
ADVANTAGE MALARIA STIX is a visual, rapid and sensitive immunoassay for the qualitative differential detection of P.falciparum (P.f) and P.vivax (P.v) malaria in Human Blood only....
Malaria device / strip (2 line, P.f.-HRP2 Test)...
Medicine Products: